awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q33504409-3F79DA19-9FD8-4BF5-A145-B8DDE2132224
Q33504409-3F79DA19-9FD8-4BF5-A145-B8DDE2132224
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33504409-3F79DA19-9FD8-4BF5-A145-B8DDE2132224
A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion.
P433
Q33504409-3F79DA19-9FD8-4BF5-A145-B8DDE2132224
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33504409-3F79DA19-9FD8-4BF5-A145-B8DDE2132224
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a153465d02e89cf92ff08385dbc673ebc5e84e5e
P433
10
http://www.w3.org/2001/XMLSchema#string